- Home
- Publications
- Publication Search
- Publication Details
Title
Activation of the JAK/STAT pathway in Behcet’s disease
Authors
Keywords
-
Journal
GENES AND IMMUNITY
Volume 16, Issue 2, Pages 170-175
Publisher
Springer Nature
Online
2014-11-20
DOI
10.1038/gene.2014.64
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic variants in the JAK1 gene confer higher risk of Behcet’s disease with ocular involvement in Han Chinese
- (2013) Shengping Hou et al. HUMAN GENETICS
- Gene expression profiling and association studies implicate the neuregulin signaling pathway in Behçet's disease susceptibility
- (2013) Joana M. Xavier et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Expression of Th-17 and RORgammat mRNA in Behçet’s Disease
- (2013) Kamel Hamzaoui et al. MEDICAL SCIENCE MONITOR
- Inflammatory pathways in spondyloarthritis
- (2013) Hulda S. Hreggvidsdottir et al. MOLECULAR IMMUNOLOGY
- Identification of multiple independent susceptibility loci in the HLA region in Behçet's disease
- (2013) Travis Hughes et al. NATURE GENETICS
- JAKs and STATs in Immunity, Immunodeficiency, and Cancer
- (2013) John J. O'Shea et al. NEW ENGLAND JOURNAL OF MEDICINE
- Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease
- (2013) Mehmet Coskun et al. PHARMACOLOGICAL RESEARCH
- Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives - an update
- (2012) Newman Yeilding et al. Annals of the New York Academy of Sciences
- Influence of the STAT3 genetic variants in the susceptibility to psoriatic arthritis and Behcet’s disease
- (2012) María Carmen Cénit et al. HUMAN IMMUNOLOGY
- JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
- (2012) John J. O'Shea et al. IMMUNITY
- Mechanisms of Unphosphorylated STAT3 Transcription Factor Binding to DNA
- (2012) Olga A. Timofeeva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease
- (2012) Sunao Sugita et al. ARTHRITIS RESEARCH & THERAPY
- Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease
- (2011) J. Shimizu et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Regulation of TH17 and regulatory T cells in patients with Behçet disease
- (2011) Haner Direskeneli et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease
- (2011) Guillaume Geri et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Autoreactive Memory CD4+ T Lymphocytes That Mediate Chronic Uveitis Reside in the Bone Marrow through STAT3-Dependent Mechanisms
- (2011) H.-M. Oh et al. JOURNAL OF IMMUNOLOGY
- Diverse Targets of the Transcription Factor STAT3 Contribute to T Cell Pathogenicity and Homeostasis
- (2010) Lydia Durant et al. IMMUNITY
- Stat3-dependent acute Rantes production in vascular smooth muscle cells modulates inflammation following arterial injury in mice
- (2010) Jason C. Kovacic et al. JOURNAL OF CLINICAL INVESTIGATION
- Genome-wide association study identifies variants in the MHC class I, IL10 and IL23R-IL12RB2 regions associated with Behçet's disease
- (2010) Elaine F Remmers et al. NATURE GENETICS
- IFN- blocks IL-17 production by peripheral blood mononuclear cells in Behcet's disease
- (2010) X. Liu et al. RHEUMATOLOGY
- Type 17 T helper cells—origins, features and possible roles in rheumatic disease
- (2009) Francesco Annunziato et al. Nature Reviews Rheumatology
- Roles of unphosphorylated STATs in signaling
- (2008) Jinbo Yang et al. CELL RESEARCH
- Interleukin-6 in neuro-Behçet’s disease: Association with disease subsets and long-term outcome
- (2008) Gülşen Akman-Demir et al. CYTOKINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started